Are measures of body habitus associated with mortality in cystic fibrosis?

Chest

Volumn 142, Issue 3, 2012, Pages 712-717

  Fogarty, Andrew W ^a   Britton, John ^a   Clayton, Andy ^b   Smyth, Alan R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADOLESCENT; ADULT; ARTICLE; BODY BUILD; BODY HEIGHT; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; DEATH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE MASS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; UNITED KINGDOM;

EID: 84865837418     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2124     Document Type: Article

References (34)

1. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373(9678):1891- 1904.
2. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol. 1997;145(9):794-803. (Pubitemid 27188516)
3. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr. 1993;122(1):1-9. (Pubitemid 23010675)
4. Britton JR. Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ. 1989;298(6672):483-487. (Pubitemid 19072074)
5. Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol. 1996;143(10):1007-1017. (Pubitemid 26140328)
6. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol. 1995;48(8):1041-1049.
7. Dodge JA, Morison S, Lewis PA, et al UK Cystic Fibrosis Survey Management Committee. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. Arch Dis Child. 1997;77(6):493-496. (Pubitemid 28016366)
8. Huang NN, Schidlow DV, Szatrowski TH, et al. Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med. 1987;82(5):871-879.
9. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992;326(18):1187-1191.
10. Fogarty A, Hubbard R, Britton J. International comparison of median age at death from cystic fibrosis. Chest. 2000;117(6):1656-1660. (Pubitemid 30413359)
11. Beker LT, Russek-Cohen E, Fink RJ. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc. 2001;101(4):438-442. (Pubitemid 33712127)
12. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583-591.
13. Courtney JM, Bradley J, Mccaughan J, et al. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol. 2007;42(6):525-532. (Pubitemid 46870384)
14. Chamnan P, Shine BS, Haworth CS, Bilton D, Adler AI. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care. 2010;33(2):311-316.
15. Vestbo J, Prescott E, Almdal T, et al. Body mass, free-fat body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample. Am J Respir Crit Care Med. 2006;173(1):79-83. (Pubitemid 43069791)
16. Oterdoom LH, Gansevoort RT, Schouten JP, de Jong PE, Gans RO, Bakker SJ. Urinary creatinine excretion, an indi rect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population . Atherosclerosis. 2009;207(2):534-540.
17. Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG. Total plasma creatinine: an accurate measure of total striated muscle mass. J Appl Physiol. 1981;51(3):762-766. (Pubitemid 11002822)
18. Mehta G, Sims EJ, Culross F, McCormick JD, Mehta A. Poten tial benefits of the UK cystic fibrosis database. J R Soc Med. 2004;97(suppl 44):60-71. (Pubitemid 38680177)
19. Bertenshaw C, Watson AR, Lewis S, Smyth A. Survey of acute renal failure in patients with cystic fibrosis in the UK. Thorax. 2007;62(6):541-545. (Pubitemid 46910136)
20. Heymsfield SB, Gallagher D, Visser M, Nuñez C, Wang Z-M. Measurement of skeletal muscle: laboratory and epidemiological methods. J Gerontol A Biol Sci Med Sci. 1995;50(specno):23-29.
21. Lukaski H. Sarcopenia: assessment of muscle mass. J Nutr. 1997;127(suppl 5):994S-997S. (Pubitemid 27209488)
22. Morrison J, Nayiager T, Webber CE, Sala A, Barr R. Creatinine as a measure of lean body mass during treatment of acute lymphoblastic leukemia in childhood. J Pediatr Hematol Oncol. 2011;33(1):e13-e16.
23. Pinet C, Cassart M, Scillia P, et al. Function and bulk of respiratory and limb muscles in patients with cystic fibrosis. Am J Respir Crit Care Med. 2003;168(8):989-994. (Pubitemid 37267178)
24. Ionescu AA, Chatham K, Davies CA, Nixon LS, Enright S, Shale DJ. Inspiratory muscle function and body composition in cystic fibrosis. Am J Respir Crit Care Med. 1998;158(4):1271-1276. (Pubitemid 28489032)
25. Ionescu AA, Nixon LS, Evans WD, et al. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med. 2000;162(3 pt 1):789-794.
26. Ionescu AA, Nixon LS, Luzio S, et al. Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis. Am J Respir Crit Care Med. 2002;165(4):495-500. (Pubitemid 34165473)
27. Barry SC, Gallagher CG. Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol. 2003;95(4):1379- 1384.
28. Simmonds NJ, Macneill SJ, Cullinan P, Hodson ME. Cystic fibrosis and survival to 40 years: a case-control study. Eur Respir J. 2010;36(6):1277-1283.
29. Kraemer R, Rüdeberg A, Hadorn B, Rossi E. Relative under-weight in cystic fibrosis and its prognostic value. Acta Paediatr Scand. 1978;67(1):33-37. (Pubitemid 8277807)
30. Davey Smith G, Hart C, Upton M, et al. Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality. J Epidemiol Community Health. 2000;54(2):97-103. (Pubitemid 30066242)
31. Divangahi M, Balghi H, Danialou G, et al. Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice. PLoS Genet. 2009;5(7):e1000586.
32. Lamhonwah A-M, Bear CE, Huan LJ, Kim Chiaw P, Ackerley CA, Tein I. Cystic fibrosis transmembrane conductance regulator in human muscle: dysfunction causes abnormal metabolic recovery in exercise. Ann Neurol. 2010;67(6):802-808.
33. Troosters T, Langer D, Vrijsen B, et al. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J. 2009;33(1):99-106.
34. Verma N, Bush A, Buchdahl R. Is there still a gender gap in cystic fibrosis? Chest. 2005;128(4):2824-2834. (Pubitemid 41507646)